BioScrip Inc. reported today profits in the latest quarter more than tripled compared a year ago on higher revenues and lower operating expenses.
Net income rose to $1.6 million in the three months ending June 30, the company said, up from $482,000 in the year-ago quarter.
On a per-share basis, the Elmsford-based specialty pharmaceutical company reported it earned 4 cents a share, compared to a penny a share last year.
Revenues rose 18.2 percent to $348.4 million from $294.7 million a year ago.
Among highlights for the quarter, BioScrip noted that revenues in its specialty-services unit rose 25.3 percent above last yearâ€™s levels.